PMC:7195088 / 21101-21213
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"673","span":{"begin":68,"end":76},"obj":"Species"},{"id":"797","span":{"begin":42,"end":52},"obj":"Chemical"},{"id":"938","span":{"begin":99,"end":107},"obj":"Disease"}],"attributes":[{"id":"A673","pred":"tao:has_database_id","subj":"673","obj":"Tax:9606"},{"id":"A797","pred":"tao:has_database_id","subj":"797","obj":"MESH:C000606551"},{"id":"A938","pred":"tao:has_database_id","subj":"938","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"at days 7, 14, 21 and 28.\n• Comparison of remdesivir vs. placebo in patients with mild to moderate COVID-19. Dou"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T103","span":{"begin":99,"end":107},"obj":"Disease"}],"attributes":[{"id":"A103","pred":"mondo_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"at days 7, 14, 21 and 28.\n• Comparison of remdesivir vs. placebo in patients with mild to moderate COVID-19. Dou"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T236","span":{"begin":42,"end":52},"obj":"Chemical"}],"attributes":[{"id":"A236","pred":"chebi_id","subj":"T236","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"}],"text":"at days 7, 14, 21 and 28.\n• Comparison of remdesivir vs. placebo in patients with mild to moderate COVID-19. Dou"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T148","span":{"begin":26,"end":108},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"at days 7, 14, 21 and 28.\n• Comparison of remdesivir vs. placebo in patients with mild to moderate COVID-19. Dou"}